1[2]Bose B.Hemangioperieytoma:A cliniepathologic and ultrastrure study[J].Wodd J Surg,1981,5(6):863～871.
2[3]Gaffey MJ,Mills SE,Askin FB,et al.Clear cell tumor of the lung.Aclinicopathologic,cases[J].Am J SurgPathol,1990,14:248～259.
3[4]Gal AA,Koss MN,Hochholzer L,et al.An immunohistochemical study of benign clear cell('sugar')tumor of the lung[J].Arch Pathol Lab Med,1991,115:1034～1038.
4Folpe AL.Neoplasms with perivascular epithelioid cell differentiation (PEComas)[].World Health Organization classification of tumoursPathology and genetics of tumours of soft tissue and bone.2002
5Folpe AL,Mentzel T,Lehr HA,et al.Perivascular epitheliod cell neoplasms of soft tissue and gynecologic origin:a clinico-pathologic study of 26 cases and review of the literature[].The American Journal of Surgical Pathology.2005
6Shi HY,Wei LX,Sun L, et al.Clinicopathologic analysis of 4 perivascular epithelioid cell tumors (PEComas) of the gastrointestinal tact[].Int J Surg Pathol OnlineFirst.2010
7Ryan P,Nguyen VH,Gholoum S,et al.Polypoid PEComa in the rectum of a 15-year-old girl;case report and review of PEComa in the gastrointestinal tract[].The American Journal of Surgical Pathology.2009
8Subbiah V,Trent JC,Kurzrock R.Resistance to mammalian target of rapamycin inhibitor therapy in perivascular epithelioid cell tumors[].Journal of Clinical Oncology.2010
9Wagner AJ,Malinowska-Kolodziej I,Morgan JA,Qin W,Fletcher CD,Vena N,Ligon AH,Antonescu CR,Ramaiya NH,Demetri GD,Kwiatkowski DJ,Maki RG.Clinical activ- ity of mTOR inhibition with sirolimus in malignant perivas- cular epithelioid cell tumors: targeting the pathogenic acti- vation of mTORC1 in tumors[].Journal of Clinical Oncology.2010
10Plas DR,Thomas G.Tubers and tumors: rapamycin therapy for benign and malignant tumors[].Current Opinion in Cell Biology.2009
